Epoprostenol
HealthData.Gov
Updated Mar 24, 2026
About this dataset
Epoprostenol Sodium is a prescription injectable drug administered intravenously to dilate blood vessels, often used for conditions like pulmonary hypertension. It comes as a lyophilized powder in vials with strengths of 0.5 mg or 1.5 mg, manufactured by Sun Pharmaceutical Industries, Inc. under ANDA210473. This information was generated using AI and is provided for informational and research purposes only.
Data and resources (1)
- HTML
Epoprostenol
Access the FDA dataset for Epoprostenol — ANDA 203308 submitted by Mylan Institutional LLC
Modified Dec 27, 2025